Recent and rapid emergence of W-Beijing strains of Mycobacterium tuberculosis in Cape Town, South Africa

Clinical Infectious Diseases

Volumn 47, Issue 10, 2008, Pages 1252-1259

  Cowley, Donna ^a,b   Govender, Dhirendra ^a   February, Bradley ^a   Wolfe, Mary ^a   Steyn, Lafras ^a   Evans, Joanna ^a   Wilkinson, Robert J ^a,c,d   Nicol, Mark P ^a,e  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CONTROLLED STUDY; GENOTYPE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH AFRICA; W BEIJING STRAIN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BACTERIAL TYPING TECHNIQUES; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; COMORBIDITY; DNA, BACTERIAL; EPIDEMIOLOGY, MOLECULAR; FEMALE; GENOTYPE; HIV INFECTIONS; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; SOUTH AFRICA; TUBERCULOSIS;

EID: 54249117176     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/592575     Document Type: Article

References (39)

1. Bifani PJ, Mathema B, Kurepina NE, Kreiswirth BN. Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains. Trends Microbiol 2002; 10:45-52.
2. Agerton TB, Valway SE, Blinkhorn RJ, et al. Spread of strain W, a highly drug-resistant strain of Mycobacterium tuberculosis, across the United States. Clin Infect Dis 1999; 29:85-92.
3. Kong Y, Cave MD, Zhang L, et al. Association between Mycobacterium tuberculosis Beijing/W lineage strain infection and extrathoracic tuberculosis: insights from epidemiologic and clinical characterization of the three principal genetic groups of M. tuberculosis clinical isolates. J Clin Microbiol 2007; 45:409-14.
4. Caws M, Thwaites G, Stepniewska K, et al. Beijing genotype of Mycobacterium tuberculosis is significantly associated with human immunodeficiency virus infection and multidrug resistance in cases of tuberculous meningitis. J Clin Microbiol 2006; 44:3934-9.
5. Manca C, Tsenova L, Freeman S, et al. Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway. J Interferon Cytokine Res 2005; 25:694-701.
6. Tsenova L, Ellison E, Harbacheuski R, et al. Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit model of meningitis is dependent on phenolic glycolipid produced by the bacilli. J Infect Dis 2005; 192:98-106.
7. Grode L, Seiler P, Baumann S, et al. Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin. J Clin Invest 2005; 115:2472-9.
8. European Concerted Action on New Generation Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis. Beijing/W genotype Mycobacterium tuberculosis and drug resistance. Emerg Infect Dis 2006; 12:736-43.
9. Gagneux S, Deriemer K, Van T, et al. Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 2006; 103:2869-73.
10. Marais BJ, Victor TC, Hesseling AC, et al. Beijing and Haarlem genotypes are overrepresented among children with drug-resistant tuberculosis in the Western Cape Province of South Africa. J Clin Microbiol 2006; 44:3539-43.
11. Nicol MP, Sola C, February B, Rastogi N, Steyn L, Wilkinson RJ. Distribution of strain families of Mycobacterium tuberculosis causing pulmonary and extrapulmonary disease in hospitalized children in Cape Town, South Africa. J Clin Microbiol 2005; 43:5779-81.
12. Day C, Gray A. Health and related indicators. In: Ijumba P, Padarath A, eds. South African Health Report 2006. Durban: Health Systems Trust, 2006:369-506.
13. Zar HJ, Hanslo D, Apolles P, Swingler G, Hussey G. Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study. Lancet 2005; 365:130-4.
14. Toms IP. City of Cape Town/Metropole Region TB control programme progress report 1997-2002. Cape Town, South Africa: City of Cape Town, 2003.
15. Qian L, Van Embden JD, van der Zanden AG, Weltevreden EF, Duanmu H, Douglas JT. Retrospective analysis of the Beijing family of Mycobacterium tuberculosis in preserved lung tissues. J Clin Microbiol 1999; 37:471-4.
16. Kamerbeek J, Schouls L, Kolk A, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997; 35:907-14.
17. Filliol I, Motiwala AS, Cavatore M, et al. Global phylogeny of Mycobacterium tuberculosis based on single nucleotide polymorphism (SNP) analysis: insights into tuberculosis evolution, phylogenetic accuracy of other DNA fingerprinting systems, and recommendations for a minimal standard SNP set. J Bacteriol 2006; 188:759-72.
18. Brudey K, Driscoll JR, Rigouts L, et al. Mycobacterium tuberculosis complex genetic diversity: mining the Fourth International Spoligotyping Database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol 2006; 6:23.
19. Richardson M, van Lill SW, van der Spuy GD, et al. Historic and recent events contribute to the disease dynamics of Beijing-like Mycobacterium tuberculosis isolates in a high incidence region. Int J Tuberc Lung Dis 2002; 6:1001-11.
20. Kremer K, Glynn JR, Lillebaek T, et al. Definition of the Beijing/W lineage of Mycobacterium tuberculosis on the basis of genetic markers. J Clin Microbiol 2004; 42:4040-9.
21. Pavelic J, Gall-Troselj K, Bosnar MH, Kardum MM, Pavelic K. PCR amplification of DNA from archival specimens: a methodological approach. Neoplasma 1996; 43:75-81.
22. Caminero JA, Pena MJ, Campos-Herrero MI, et al. Epidemiological evidence of the spread of a Mycobacterium tuberculosis strain of the Beijing genotype on Gran Canaria Island. Am J Respir Crit Care Med 2001; 164:1165-70.
23. Narvskaya O, Otten T, Limeschenko E, et al. Nosocomial outbreak of multidrug-resistant tuberculosis caused by a strain of Mycobacterium tuberculosis W-Beijing family in St. Petersburg, Russia. Eur J Clin Microbiol Infect Dis 2002; 21:596-602.
24. Anh DD, Borgdorff MW, Van LN, et al. Mycobacterium tuberculosis Beijing genotype emerging in Vietnam. Emerg Infect Dis 2000; 6:302-5.
25. Kok P, Gelderblom D, van Zyl J. Introduction. In: Kok P, Gelderblom D, Oucho J, van Zyl J, eds. Migration in South and southern Africa: dynamics and determinants. Cape Town, South Africa: HSRC Press, 2006:1-24.
26. Metcalf C. A history of tuberculosis. In: Coovadia HM, Benatar SR, eds. A century of tuberculosis: South African perspectives. Cape Town, South Africa: Oxford University Press, 1991:1-31.
27. van der Ross RE. Myths and attitudes: an inside look at the Coloured people. Cape Town, South Africa: Tafelberg, 1979.
28. Victor TC, de Haas PE, Jordaan AM, et al. Molecular characteristics and global spread of Mycobacterium tuberculosis with a western cape F11 genotype. J Clin Microbiol 2004; 42:769-72.
29. Almeida D, Rodrigues C, Ashavaid TF, Lalvani A, Udwadia ZF, Mehta A. High incidence of the Beijing genotype among multidrug-resistant isolates of Mycobacterium tuberculosis in a tertiary care center in Mumbai, India. Clin Infect Dis 2005; 40:881-6.
30. Cox HS, Kubica T, Doshetov D, Kebede Y, Rusch-Gerdess S, Niemann S. The Beijing genotype and drug resistant tuberculosis in the Aral Sea region of Central Asia. Respir Res 2005; 6:134.
31. Toungoussova OS, Mariandyshev A, Bjune G, Sandven P, Caugant DA. Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates in the Archangel prison in Russia: predominance of the W-Beijing clone family. Clin Infect Dis 2003; 37:665-72.
32. Frieden TR, Sherman LF, Maw KL, et al. A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes. JAMA 1996; 276:1229-35.
33. Corbett EL, Charalambous S, Moloi VM, et al. Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners. Am J Respir Crit Care Med 2004; 170:673-9.
34. Reed MB, Domenech P, Manca C, et al. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 2004; 431:84-7.
35. Ordway D, Henao-Tamayo M, Harton M, et al. The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation. J Immunol 2007; 179:522-31.
36. Reed MB, Gagneux S, Deriemer K, Small PM, Barry CE III. The W-Beijing lineage of Mycobacterium tuberculosis overproduces triglycerides and is constitutively upregulated for the DosR dormancy regulon constitutively upregulated. J Bacteriol 2007; 189:2583-9.
37. Di Perri G, Cazzadori A, Vento S, et al. Comparative histopathological study of pulmonary tuberculosis in human immunodeficiency virus-infected and non-infected patients. Tuber Lung Dis 1996; 77:244-9.
38. Abebe F, Bjune G. The emergence of Beijing family genotypes of Mycobacterium tuberculosis and low-level protection by bacille Calmette-Guerin (BCG) vaccines: is there a link? Clin Exp Immunol 2006; 145:389-97.
39. Tsenova L, Harbacheuski R, Sung N, Ellison E, Fallows D, Kaplan G. BCG vaccination confers poor protection against M. tuberculosis HN878-induced central nervous system disease. Vaccine 2007; 25:5126-32.